Year: 2012
Type: review
Abstract: Mantle cell lymphoma is a B cell malignancy in which constitutive dysregulation of cyclin D1 and the cell cycle, disruption of DNA damage response pathways, and activation of cell survival mechanisms contribute to oncogenesis.A small number of tumors lack cyclin D1 overexpression, suggesting that its dysregulation is always not required for tumor initiation.Some cases have hypermutated IGHV and stable karyotypes, a predominant nonnodal disease, and an indolent clinical evolution, which suggests that they may correspond to distinct subtypes of the disease.In this review, we discuss the molecular pathways that contribute to pathogenesis, and how improved understanding of these molecular mechanisms offers new perspectives for the treatment of patients.the European Mantle Cell Lymphoma Network and the Mantle Cell Lymphoma Consortium of the Lymphoma Research Foundation for their continuous collaboration on these projects.
DOI: 10.1172/jci61272
Authors: Pedro Jares, Dolors Colomer, Elias Campo
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Award: G1952936224
OpenAlex ID: W2040669551
